Kathleen Brady to Attention Deficit Disorder with Hyperactivity
This is a "connection" page, showing publications Kathleen Brady has written about Attention Deficit Disorder with Hyperactivity.
Connection Strength
0.901
-
A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder. Am J Addict. 2010 Nov-Dec; 19(6):481-9.
Score: 0.295
-
Attention-deficit/hyperactivity disorder, medication treatment, and substance use patterns among adolescents and young adults. J Child Adolesc Psychopharmacol. 2005 Oct; 15(5):799-809.
Score: 0.209
-
Methylphenidate transdermal system in adults with past stimulant misuse: an open-label trial. J Atten Disord. 2011 Oct; 15(7):539-44.
Score: 0.072
-
Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addict Behav. 2008 Sep; 33(9):1199-207.
Score: 0.063
-
Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend. 2008 Jul 01; 96(1-2):145-54.
Score: 0.062
-
Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress. Am J Psychiatry. 2005 Aug; 162(8):1483-93.
Score: 0.052
-
Bupropion SR in adolescents with comorbid ADHD and nicotine dependence: a pilot study. J Am Acad Child Adolesc Psychiatry. 2004 Feb; 43(2):199-205.
Score: 0.047
-
Venlafaxine treatment of patients with comorbid alcohol/cocaine abuse and attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychopharmacol. 2001 Feb; 21(1):116-8.
Score: 0.038
-
Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice. Am J Drug Alcohol Abuse. 1999 Aug; 25(3):441-8.
Score: 0.034
-
Dual diagnosis in primary care. Detecting and treating both the addiction and mental illness. Med Clin North Am. 1997 Jul; 81(4):1017-36.
Score: 0.029